Nextech Invest

Portfolio Companies 2026 for Nextech Invest: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Nextech Invest accounts for 23 tracked companies with verified cap-table data, 23 of which disclose round sizes totalling $4.9B. The median disclosed raise is $136M, and the largest is Autolus at $1.2B, ahead of Vividion Therapeutics ($362M) and FogPharma ($323M).

The names that recur most often on these portfolio cap tables are Nextech Invest (24 companies), RA Capital Management (8 companies), Casdin Capital (7 companies), Third Rock Ventures (5 companies), Boxer Capital (5 companies), OrbiMed (5 companies). By latest disclosed round, the market skews Series C (9), Series A (7), Series B (4), IPO (1).

Best funded Nextech Invest companies

  1. Autolus — $1.2B (latest: IPO)
  2. Vividion Therapeutics — $362M (latest: Series B)
  3. FogPharma — $323M (latest: Series D)
  4. Flare Therapeutics — $287M (latest: Series C)
  5. Boundless Bio — $256M (latest: Series C)
  6. ProfoundBio — $250M (latest: Series B)
  7. Escient Pharmaceuticals — $238M (latest: Series C)
  8. Alterome Therapeutics — $231M (latest: Series A)
  9. Kinnate Biopharma — $195M (latest: Series C)
  10. Black Diamond Therapeutics — $194M (latest: Series C)
  11. Tyra Biosciences — $156M (latest: Series B)
  12. A2 Biotherapeutics — $136M (latest: Series C)
  13. Idrx — $122M (latest: Series A)
  14. Blueprint Medicines — $115M (latest: Series C)
  15. Jounce Therapeutics — $103M (latest: Series B)

Nextech Invest — related firms and companies (56)

Nextech Invest profile · All research reports